Page last updated: 2024-11-01

omeprazole and Sjogren's Syndrome

omeprazole has been researched along with Sjogren's Syndrome in 2 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balbir-Gurman, A1
Brook, OR1
Chermesh, I1
Braun-Moscovici, Y1
Fiebiger, W1
Stummvoll, G1
Weinländer, G1
Raderer, M1

Reviews

1 review available for omeprazole and Sjogren's Syndrome

ArticleYear
Pneumatosis cystoides intestinalis in scleroderma-related conditions.
    Internal medicine journal, 2012, Volume: 42, Issue:3

    Topics: Abdomen, Acute; Adrenal Cortex Hormones; Adult; Aged; Connective Tissue Diseases; Diagnosis, Differe

2012

Other Studies

1 other study available for omeprazole and Sjogren's Syndrome

ArticleYear
Does pantoprazole alleviate mouth dryness in patients with Sjögren's syndrome?
    Rheumatology (Oxford, England), 2001, Volume: 40, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Female; Humans; Middle A

2001